AI Summary of Peer-Reviewed Research
This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. See full disclosure ↓
⚠️ This article summarizes published research and is intended for informational purposes only. It does not constitute medical advice or clinical guidance.
Publication Signals show what we were able to verify about where this research was published.MODERATECore publication signals for this source were verified. Publication Signals reflect the source’s verifiable credentials, not the quality of the research.
- ✔ Peer-reviewed source
- ✔ Published in indexed journal
- ✔ No retraction or integrity flags
Overview
This cohort study examines the association between adverse childhood experiences (ACEs) and treatment-resistant depression (TRD) in individuals with major depressive disorder (MDD). The analysis accounts for unmeasured familial confounding through cohort design methodology, establishing ACE exposure as an independent risk factor for treatment-resistant outcomes in depression.
Methods and approach
The study employed a cohort design framework to investigate the relationship between ACE exposure and TRD development among MDD patients. The analytical approach incorporated statistical control for familial confounding through cohort-based comparisons, enabling assessment of the independent contribution of ACE history to treatment resistance. The design enabled evaluation of whether observed associations persist after accounting for unmeasured confounding attributable to shared familial factors.
Key Findings
ACE exposure demonstrated a significant association with elevated risk of TRD persisting after adjustment for unmeasured familial confounding. The findings indicate that childhood adversity exposure represents an independent risk factor for treatment-resistant outcomes in depression, operating beyond the influence of shared genetic and environmental factors within families.
Implications
The findings establish ACE history as a clinically relevant factor in stratifying MDD patients by treatment resistance risk. Integration of comprehensive ACE assessment into routine clinical evaluation for MDD may identify individuals at elevated likelihood of requiring alternative or augmentation treatment strategies, potentially improving treatment selection and clinical outcomes. The persistence of associations despite familial confounding control suggests direct pathways from early adversity to treatment resistance mechanisms warrant further investigation.
Scope and limitations
This summary is based on the study abstract and available metadata. It does not include a full analysis of the complete paper, supplementary materials, or underlying datasets unless explicitly stated. Findings should be interpreted in the context of the original publication.
Disclosure
- Research title: Adverse Childhood Experiences and Treatment-Resistant Depression
- Authors: Ying Xiong, Philip Lindersten, Tong Gong, P. O. Magnusson, S. Liu, Yi Lu
- Institutions: Karolinska Institutet, University of Edinburgh
- Publication date: 2026-03-12
- DOI: https://doi.org/10.1001/jamanetworkopen.2026.0222
- OpenAlex record: View
- Image credit: Photo by Christina @ wocintechchat.com M on Unsplash (Source • License)
- Disclosure: This post was generated by Claude (Anthropic). The original authors did not write or review this post.
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.


